Literature DB >> 29203575

Chronic Δ9-THC in Rhesus Monkeys: Effects on Cognitive Performance and Dopamine D2/D3 Receptor Availability.

William S John1, Thomas J Martin1, Kiran Kumar Solingapuram Sai1, Susan H Nader1, H Donald Gage1, Akiva Mintz1, Michael A Nader2.   

Abstract

Cannabis-related impairments to cognitive function may represent novel therapeutic targets for cannabis-use disorder, although the nature, persistence, and reversibility of such deficits remain unclear. Adult male rhesus monkeys (N = 6) responded in the morning on tasks designed to assess different cognitive domains using the Cambridge Neuropsychological Test Automated Battery (CANTAB) touchscreens followed by responding maintained under a fixed-ratio (FR) 10 schedule of food presentation in different operant chambers. First, the acute effects of Δ9-tetrahydrocannabinol (THC; 0.01-0.56 mg/kg, i.v.) on cognitive performance, FR responding, and body temperature were determined. Next, THC (1.0-2.0 mg/kg, s.c.) was administered daily after FR 10 sessions for 12 weeks, during which the residual effects of THC (i.e., 22 hours after administration) on cognition were examined and the acute effects of THC were redetermined. In a subgroup of monkeys, dopamine D2/D3 receptor availability was assessed after 4 weeks of chronic THC exposure and compared with drug-naive controls using positron emission tomography and [11C]-raclopride (N = 4/group). Acute THC pretreatments dose-dependently decreased FR responding and body temperature, and impairment to cognitive performance was task specific. During chronic treatment, THC produced persistent residual impairment only to working memory; tolerance differentially developed to acute cognitive impairments. There was recovery from residual cognitive impairments to working memory within 2 weeks of abstinence. Compared with controls, D2/D3 receptor availability was not altered during chronic THC treatment. In conclusion, THC-induced disruptions in cognition were task-specific, as was tolerance development, and not related to changes in D2/D3 receptor availability. Intervention strategies for cannabis-use disorder that enhance working memory performance may facilitate positive treatment outcomes.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29203575      PMCID: PMC5774214          DOI: 10.1124/jpet.117.244194

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  67 in total

1.  Striatal dopamine D₂/D₃ receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans.

Authors:  Dara G Ghahremani; Buyean Lee; Chelsea L Robertson; Golnaz Tabibnia; Andrew T Morgan; Natalie De Shetler; Amira K Brown; John R Monterosso; Adam R Aron; Mark A Mandelkern; Russell A Poldrack; Edythe D London
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

2.  Abnormal brain activity in prefrontal brain regions in abstinent marijuana users.

Authors:  Dana A Eldreth; John A Matochik; Jean L Cadet; Karen I Bolla
Journal:  Neuroimage       Date:  2004-11       Impact factor: 6.556

3.  Real-world memory and executive processes in cannabis users and non-users.

Authors:  J E Fisk; C Montgomery
Journal:  J Psychopharmacol       Date:  2008-01-21       Impact factor: 4.153

4.  Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity.

Authors:  Nora D Volkow; Gene-Jack Wang; Frank Telang; Joanna S Fowler; David Alexoff; Jean Logan; Millard Jayne; Christopher Wong; Dardo Tomasi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

5.  Primate analogue of the Wisconsin Card Sorting Test: effects of excitotoxic lesions of the prefrontal cortex in the marmoset.

Authors:  R Dias; T W Robbins; A C Roberts
Journal:  Behav Neurosci       Date:  1996-10       Impact factor: 1.912

6.  Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs.

Authors:  Jennifer L Stewart; Lance R McMahon
Journal:  J Pharmacol Exp Ther       Date:  2010-04-07       Impact factor: 4.030

7.  Neurophysiological and cognitive effects of smoked marijuana in frequent users.

Authors:  Carl L Hart; Aaron B Ilan; Alan Gevins; Erik W Gunderson; Kemi Role; Jana Colley; Richard W Foltin
Journal:  Pharmacol Biochem Behav       Date:  2010-06-18       Impact factor: 3.533

8.  Δ(9)Tetrahydrocannabinol impairs reversal learning but not extra-dimensional shifts in rhesus macaques.

Authors:  M J Wright; S A Vandewater; L H Parsons; M A Taffe
Journal:  Neuroscience       Date:  2013-01-16       Impact factor: 3.590

9.  Comparisons of Δ9-Tetrahydrocannabinol and Anandamide on a Battery of Cognition-Related Behavior in Nonhuman Primates.

Authors:  Brian D Kangas; Michael Z Leonard; Vidyanand G Shukla; Shakiru O Alapafuja; Spyros P Nikas; Alexandros Makriyannis; Jack Bergman
Journal:  J Pharmacol Exp Ther       Date:  2016-01-29       Impact factor: 4.030

10.  Cannabis and tolerance: acute drug impairment as a function of cannabis use history.

Authors:  J G Ramaekers; J H van Wel; D B Spronk; S W Toennes; K P C Kuypers; E L Theunissen; R J Verkes
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

View more
  8 in total

Review 1.  Cannabis use and cannabis use disorder.

Authors:  Jason P Connor; Daniel Stjepanović; Bernard Le Foll; Eva Hoch; Alan J Budney; Wayne D Hall
Journal:  Nat Rev Dis Primers       Date:  2021-02-25       Impact factor: 52.329

Review 2.  Anatomy and Function of Ventral Tegmental Area Glutamate Neurons.

Authors:  Jing Cai; Qingchun Tong
Journal:  Front Neural Circuits       Date:  2022-05-20       Impact factor: 3.342

3.  Recovery from impaired working memory performance during chronic Δ-9-tetrahydrocannabinol administration to adolescent rhesus monkeys.

Authors:  Christopher D Verrico; David S Mathai; Hong Gu; Allan R Sampson; David A Lewis
Journal:  J Psychopharmacol       Date:  2019-10-17       Impact factor: 4.153

4.  Optogenetic brain-stimulation reward: A new procedure to re-evaluate the rewarding versus aversive effects of cannabinoids in dopamine transporter-Cre mice.

Authors:  Bree A Humburg; Chloe J Jordan; Hai-Ying Zhang; Hui Shen; Xiao Han; Guo-Hua Bi; Briana Hempel; Ewa Galaj; Michael H Baumann; Zheng-Xiong Xi
Journal:  Addict Biol       Date:  2021-02-03       Impact factor: 4.093

Review 5.  Cannabinoid disruption of learning mechanisms involved in reward processing.

Authors:  Carl R Lupica; Alexander F Hoffman
Journal:  Learn Mem       Date:  2018-08-16       Impact factor: 2.460

Review 6.  A systematic review of neuroimaging and acute cannabis exposure in age-of-risk for psychosis.

Authors:  Lani Cupo; Eric Plitman; Elisa Guma; M Mallar Chakravarty
Journal:  Transl Psychiatry       Date:  2021-04-13       Impact factor: 6.222

7.  Effects of chronic cocaine and ethanol self-administration on brain dopamine receptors in a rhesus monkey model of polysubstance abuse.

Authors:  Felicity M Say; Aaron M Tryhus; Phillip M Epperly; Susan H Nader; Kiran K Solingapuram Sai; Brianna E George; Haley A Kirse; Paul W Czoty
Journal:  Addict Biol       Date:  2022-09       Impact factor: 4.093

8.  Hematological and biochemical parameters for Chinese rhesus macaque.

Authors:  Wenhai Yu; Xianhui Hao; Fengmei Yang; Jin Ma; Yuan Zhao; Yanyan Li; Junbin Wang; Hongjie Xu; Lixiong Chen; Quan Liu; Suqin Duan; Yaping Yang; Fen Huang; Zhanlong He
Journal:  PLoS One       Date:  2019-09-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.